HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

HTG Molecular Diagnostics (Nasdaq: HTGM) will participate virtually in the H.C. Wainwright Global Investment Conference from May 23-26, 2022. Management's presentation is scheduled for May 24 at 7:00 AM Eastern Time, available on demand. Attendees can also arrange one-on-one virtual meetings with management. HTG focuses on advancing precision medicine through its transcriptome-wide profiling technology, enhancing translational research and diagnostics across various diseases. For more details, visit www.htgmolecular.com.

TUCSON, Ariz., May 17, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate virtually in the H.C. Wainwright Global Investment Conference being held May 23-26, 2022.

Details for the conference presentation are below:

Date:	Tuesday, May 24
Time:	7:00 AM Eastern Time (On Demand)

Management will also be available for one-on-one virtual meetings. If you would like to request a meeting please register here.

About HTG:

HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.

Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.

HTG Investor Contact:                    

Ashley Robinson                        
LifeSci Advisors                         
Phone: (617) 430-7577                
Email: arr@lifesciadvisors.com        

 

FAQ

What event will HTG Molecular Diagnostics participate in May 2022?

HTG Molecular Diagnostics will participate in the H.C. Wainwright Global Investment Conference from May 23-26, 2022.

When is HTG's presentation at the H.C. Wainwright Conference?

HTG's presentation is scheduled for May 24, 2022, at 7:00 AM Eastern Time.

How can investors schedule meetings with HTG management during the conference?

Investors can request one-on-one virtual meetings with HTG management by registering through the provided link in the press release.

What technology does HTG Molecular Diagnostics focus on?

HTG focuses on transcriptome-wide profiling technology to advance precision medicine.

What are HTG's goals in precision medicine?

HTG aims to enhance translational research, clinical diagnostics, and targeted therapeutics across various disease areas.